NASDAQ:ICVX - Nasdaq - US45114M1099 - Common Stock - Currency: USD
TTM (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 0.00 | 580.00K | 7.80M | 1.62M | 0.00 | |||
Operating Expenses | 105.89M | 95.64M | 73.67M | 20.33M | 5.40M | |||
Research and Development | 70.05M | 65.41M | 38.78M | 17.67M | 4.16M | |||
Selling, General, and Administrative Expenses | 35.85M | 30.23M | 34.89M | 2.66M | 1.24M | |||
Operating Income | -105.89M | -95.06M | -65.87M | -18.71M | -5.40M | |||
Interest Income/Expense | 9.17M | 3.30M | -360.00K | -140.00K | 100.00K | |||
Non Recurring Items | N/A | 0.00 | -750.00K | N/A | N/A | |||
Income Before Taxes | -96.71M | -91.76M | -66.97M | -18.85M | -5.30M | |||
Net Income | -96.71M | -91.76M | -66.97M | -18.85M | -5.97M | |||
EBITDA | -103.20M | -94.20M | -65.79M | N/A | N/A | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -2.22 | -2.31 | -3.73 | -0.50 | -0.16 | |||
Non GAAP EPS | -2.22 | -2.31 | N/A | N/A | N/A | |||
Statistics | ||||||||
Profit Margin | N/A | -15820.69% | -858.59% | -1163.58% | N/A | |||
Operating Profit Margin | N/A | -16389.66% | -844.49% | -1154.94% | N/A |
All data in USD